Company: SCLXW
Filing Date: 2025-02-27
Form Type: DEF 14A
Source: 0001193125-25-039223
Chunk: 38

Company: Scilex Holding Co
Filing Date: 2025-02-27
Form: DEF 14A
Chunk 38
---
     |        |       | * |     |                          |          — |     |           |      — |   |     |       |       | * |
| Yue Alexander Wu, Ph.D.(8)                                      |     |              |    530,139 |     |     |        |       | * |     |                          |          — |     |           |      — |   |     |       |       | * |
| All Directors and Executive Officers as a Group (7 individuals) |     |              | 20,059,688 |     |     |        |  7.65 | % |     |                          |          — |     |           |      — |   |     |       |  6.80 | % |
| 5% Beneficial Owners                                            |     |              |            |     |     |        |       |   |     |                          |            |     |           |        |   |     |       |       |   |
| SCLX Stock Acquisition JV LLC                                   |     |              | 51,529,831 |  -9 |     |        | 21.14 | % |     |                          | 29,057,097 |     |           | 100.00 | % |     |       | 30.44 | % |
| Oramed Pharmaceuticals Inc.                                     |     |              | 15,500,000 | -10 |     |        |  6.20 | % |     |                          |            |     |           |        |   |     |       |  5.49 | % |

| * | Less than 1%. |

| (1) | Unless otherwise indicated, the business address of each of the following individuals is 960 San Antonio 
 Road, Palo Alto, CA 94303.                                                                               |

24

| (2) | Represents 10,744,999 shares subject to options exercisable within 60 days of January 31, 2025, 139,333                                 
 shares held directly and an aggregate of 155,882 shares held by family trusts for the benefit of Mr. Shah, his spouse and his children. |

| (3) | Represents 6,977,541 shares subject to options exercisable within 60 days of January 31, 2025, 320,161                                                                                                                              
 shares held directly, an aggregate of 62,819 shares held through an entity owned by Dr. Ji, 5,640 shares